Literature DB >> 8888921

Abnormal intestinal permeability in children with autism.

P D'Eufemia1, M Celli, R Finocchiaro, L Pacifico, L Viozzi, M Zaccagnini, E Cardi, O Giardini.   

Abstract

We determined the occurrence of gut mucosal damage using the intestinal permeability test in 21 autistic children who had no clinical and laboratory findings consistent with known intestinal disorders. An altered intestinal permeability was found in 9 of the 21 (43%) autistic patients, but in none of the 40 controls. Compared to the controls, these nine patients showed a similar mean mannitol recovery, but a significantly higher mean lactulose recovery (1.64% +/- 1.43 vs 0.38% +/- 0.14; P < 0.001). We speculate that an altered intestinal permeability could represent a possible mechanism for the increased passage through the gut mucosa of peptides derived from foods with subsequent behavioural abnormalities.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8888921     DOI: 10.1111/j.1651-2227.1996.tb14220.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  78 in total

1.  Metabolic approaches to the treatment of autism spectrum disorders.

Authors:  T Page
Journal:  J Autism Dev Disord       Date:  2000-10

2.  Effect of Pentavac and measles-mumps-rubella (MMR) vaccination on the intestine.

Authors:  B Thjodleifsson; K Davídsdóttir; U Agnarsson; G Sigthórsson; M Kjeld; I Bjarnason
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

Review 3.  Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy.

Authors:  J K Buitelaar; S H Willemsen-Swinkels
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

4.  Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

Authors:  Zuzana Tobiasova; Klaas H B van der Lingen; Lawrence Scahill; James F Leckman; Yan Zhang; Wookjin Chae; James T McCracken; Christopher J McDougle; Benedetto Vitiello; Elaine Tierney; Michael G Aman; L Eugene Arnold; Liliya Katsovich; Pieter J Hoekstra; Fred Volkmar; Alfred L M Bothwell; Ivana Kawikova
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-11-09       Impact factor: 2.576

Review 5.  The bowel and beyond: the enteric nervous system in neurological disorders.

Authors:  Meenakshi Rao; Michael D Gershon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-07-20       Impact factor: 46.802

Review 6.  The screening and diagnosis of autistic spectrum disorders.

Authors:  P A Filipek; P J Accardo; G T Baranek; E H Cook; G Dawson; B Gordon; J S Gravel; C P Johnson; R J Kallen; S E Levy; N J Minshew; S Ozonoff; B M Prizant; I Rapin; S J Rogers; W L Stone; S Teplin; R F Tuchman; F R Volkmar
Journal:  J Autism Dev Disord       Date:  1999-12

7.  Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder.

Authors:  Lv Wang; Claus Thagaard Christophersen; Michael Joseph Sorich; Jacobus Petrus Gerber; Manya Therese Angley; Michael Allan Conlon
Journal:  Dig Dis Sci       Date:  2012-04-26       Impact factor: 3.199

8.  Systematic reconstruction of autism biology from massive genetic mutation profiles.

Authors:  Weijun Luo; Chaolin Zhang; Yong-Hui Jiang; Cory R Brouwer
Journal:  Sci Adv       Date:  2018-04-11       Impact factor: 14.136

9.  Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism.

Authors:  Lv Wang; Claus T Christophersen; Michael J Sorich; Jacobus P Gerber; Manya T Angley; Michael A Conlon
Journal:  Appl Environ Microbiol       Date:  2011-07-22       Impact factor: 4.792

Review 10.  Autistic enterocolitis: fact or fiction?

Authors:  Polymnia Galiatsatos; Adrian Gologan; Esther Lamoureux
Journal:  Can J Gastroenterol       Date:  2009-02       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.